Oscar Health Inc. [OSCR] fell -24.33% so far this year. What now?


Oscar Health Inc. [NYSE: OSCR] price plunged by -3.26 percent to reach at -$0.2. The company report on May 10, 2022 that Oscar Health Announces Results for First Quarter 2022.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Membership as of March 31, 2022 of 1,073,595, a 98% increase YoY.

A sum of 4181314 shares traded at recent session while its average daily volume was at 1.44M shares. Oscar Health Inc. shares reached a high of $7.13 and dropped to a low of $5.90 until finishing in the latest session at $5.94.

The one-year OSCR stock forecast points to a potential upside of 43.05. The average equity rating for OSCR stock is currently 2.60, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Oscar Health Inc. [OSCR]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OSCR shares is $10.43 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OSCR stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Goldman have made an estimate for Oscar Health Inc. shares, keeping their opinion on the stock as Sell, with their previous recommendation back on February 14, 2022. While these analysts kept the previous recommendation, Wells Fargo raised their target price from $25 to $9. The new note on the price target was released on January 06, 2022, representing the official price target for Oscar Health Inc. stock. Previously, the target price had yet another raise to $6.50, while Goldman analysts kept a Sell rating on OSCR stock.

The Average True Range (ATR) for Oscar Health Inc. is set at 0.65, with the Price to Sales ratio for OSCR stock in the period of the last 12 months amounting to 0.69. The Price to Book ratio for the last quarter was 0.90, with the Price to Cash per share for the same quarter was set at 5.17.

OSCR Stock Performance Analysis:

Oscar Health Inc. [OSCR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.45. With this latest performance, OSCR shares dropped by -30.44% in over the last four-week period, additionally sinking by -63.47% over the last 6 months – not to mention a drop of -73.17% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OSCR stock in for the last two-week period is set at 27.25, with the RSI for the last a single of trading hit 19.72, and the three-weeks RSI is set at 33.19 for Oscar Health Inc. [OSCR]. The present Moving Average for the last 50 days of trading for this stock 8.32, while it was recorded at 6.65 for the last single week of trading, and 11.11 for the last 200 days.

Insight into Oscar Health Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Oscar Health Inc. [OSCR] shares currently have an operating margin of -29.61. Oscar Health Inc.’s Net Margin is presently recorded at -31.14.

Return on Equity for this stock declined to -62.37, with Return on Assets sitting at -24.95.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OSCR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Oscar Health Inc. go to 17.90%.

Oscar Health Inc. [OSCR] Insider Position Details

There are presently around $960 million, or 73.80% of OSCR stock, in the hands of institutional investors. The top three institutional holders of OSCR stocks are: THRIVE CAPITAL MANAGEMENT, LLC with ownership of 37,614,286, which is approximately 0% of the company’s market cap and around 0.20% of the total institutional ownership; BAILLIE GIFFORD & CO, holding 21,381,904 shares of the stock with an approximate value of $131.28 million in OSCR stocks shares; and GENERAL CATALYST GROUP MANAGEMENT, LLC, currently with $88.81 million in OSCR stock with ownership of nearly 0% of the company’s market capitalization.

Positions in Oscar Health Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 67 institutional holders increased their position in Oscar Health Inc. [NYSE:OSCR] by around 30,091,137 shares. Additionally, 48 investors decreased positions by around 36,838,135 shares, while 19 investors held positions by with 89,373,028 shares. The mentioned changes placed institutional holdings at 156,302,300 shares, according to the latest SEC report filing. OSCR stock had 37 new institutional investments in for a total of 19,567,685 shares, while 21 institutional investors sold positions of 14,057,788 shares during the same period.